The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer.
Willhauck MJ, Samani BR, Wolf I, Senekowitsch-Schmidtke R, Stark HJ, Meyer GJ, Knapp WH, Göke B, Morris JC, Spitzweg C.
Willhauck MJ, et al. Among authors: morris jc.
Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1272-81. doi: 10.1007/s00259-008-0775-4. Epub 2008 Apr 11.
Eur J Nucl Med Mol Imaging. 2008.
PMID: 18404268